logo-loader

Actinium Pharmaceuticals Inc

Receive alerts
Market:
NYSE
Market Cap:
$40.52 m
Price
0.25 USD
Change
-4.09%
52 weeks high
0.69
52 weeks low
0.19

In brief

Actinium is a leading biotechnology company developing targeted radioimmunotherapies for the treatment of cancer patients with unmet needs.